Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells

Cancer Lett. 2003 Jan 28;189(2):197-206. doi: 10.1016/s0304-3835(02)00500-1.

Abstract

The fungal metabolite apicidin (cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)) inhibited the growth of HL-60 cells in a concentration-dependent manner (100-1000 nM). At higher concentrations (>300 nM), cell death was induced. At 100 nM, it induced hyperacetylation of histone H4 time-dependently, while trichostatin A induced transient hyperacetylation. Apicidin (10-100 nM) increased the cells having nitroblue tetrazolium-reducing activity and expressing CD11b but not CD14 and CD15. The expression of CD11b by apicidin was long lasting, while that by trichostatin A was transient. In K562 cells, apicidin at 10-100 nM did not inhibit cell growth nor express CD11b, CD14 and CD15. Our findings indicate that apicidin inhibits proliferation and induces the early stage of differentiation of HL-60 cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation / drug effects
  • Apoptosis / drug effects
  • CD11b Antigen / analysis
  • Cell Differentiation / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology*
  • HL-60 Cells / cytology
  • HL-60 Cells / drug effects*
  • Histone Deacetylase Inhibitors*
  • Histones / metabolism
  • Humans
  • K562 Cells / drug effects
  • Lewis X Antigen / analysis
  • Lipopolysaccharide Receptors / analysis
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / metabolism
  • Peptides, Cyclic / pharmacology*
  • Protein Processing, Post-Translational / drug effects

Substances

  • CD11b Antigen
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Histones
  • Lewis X Antigen
  • Lipopolysaccharide Receptors
  • Neoplasm Proteins
  • Peptides, Cyclic
  • apicidin